Sexual dysfunction in multiple sclerosis. Psychological and behavioral factors associated with disorders or diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: Drug group: 5 grams of elderflower powder in the form of oral capsules in two divided doses 12 hours apart for one month. Intervention 2: Control group: The placebo
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women with MS in reproductive age and meta-males who have a constant sexual partner Sexual dysfunction confirmed by the test (Female Sexual Function Index (FSFI) Normal pelvic examination Pap smear negative in the last six months Normal breast examination
Exclusion criteria
Exclusion criteria: Suffering from a serious disease other than MS (any disease other than MS that requires the participant to use non-MS medications during the study) Any history of genital or gastrointestinal or breast cancer pregnancy and breastfeeding Suffering from depression or other mental disordersand taking antidepressants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of sexual dysfunction. Timepoint: The beginning of the study, one month after the start of the study. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.;Quality of life. Timepoint: The beginning of the study, one month after the start of the study. Method of measurement: Questionnaire of the quality of life of MS patients named MSQOL54.;Temperament type. Timepoint: The beginning of the study. Method of measurement: Salmannejad temperament standard questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any possible side effects. Timepoint: End of study. Method of measurement: Registration by the patient and questions from the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohadese Kamali
Kerman University of Medical Sciences
Outcome results
None listed